When Nancy Rosborough read an article in the Washington Post about growing truffles, a gourmet delicacy that’s normally harvested from the wild, the novel idea took root as a Burlington biotech company.
Seventeen bioscience companies that previously received funding from the North Carolina Biotechnology Center raised nearly $11 million in follow-on funding from other sources in the second quarter of the 2016-17 fiscal year that ended Dec. 31.
Raleigh bioscience startup Locus Biosciences, a spinout of North Carolina State University, is using a version of the hot gene-editing technology called CRISPR to cut a new path to the discovery and development of novel antibiotics.
Past and present commissioners of the U.S. Food and Drug Administration, both with ties to Duke University, are among the speakers headlining the Council for Entrepreneurial Development’s 26th annual Life Science Conference next month in Raleigh.
Oliver Smithies, D.Phil., who was recruited to North Carolina with grant funding from the North Carolina Biotechnology Center and won the Nobel Prize in Physiology or Medicine 20 years later, died today at the age of 91.